Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL-6/IL-10 mRNA expression ratio in tumor tissues predicts prognosis in gastric cancer patients without distant metastasis

12 Nov 2022

Abstract excerpt

There was growing evidence that inflammatory responses played significant roles in malignancies. However, the impact of pro-inflammatory-to-anti-inflammatory factor ratio in tumor tissues has not been investigated in gastric cancer (GC) yet. We collected patient data from The Cancer Genome Atlas (TCGA) database. A total of 270 stomach adenocarcinoma (STAD) patients without distant metastasis were included in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cancer-related molecular mechanisms research
Share to Inflammatory Biomarkers in Disease Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36371539
DOI: 10.1038/s41598-022-24189-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL-6/IL-10 mRNA expression ratio in tumor tissues predicts prognosis in gastric cancer patients without distant metastasisPMID 36371539Read ↗

Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

MiR-551b-5p deficiency associates with malignant phenotypes in gastric cancer: potential mediation by TRAF6.Semantic proximity Read ↗

The CD8⁺T/MDSC ratio: A novel prognostic and predictive biomarker for immunotherapy response in gastric cancerSemantic proximity Read ↗

Increased expression of interleukin-6 gene in gastritis and gastric cancerSemantic proximity Read ↗

IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signalingSemantic proximity Read ↗

IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung AdenocarcinomaSemantic proximity Read ↗

Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal Cancer Prognosis.Semantic proximity Read ↗

Pretreatment Platelet-to-Lymphocyte Ratio (PLR) is associated with prognosis in gastric cancer patients with immunotherapySemantic proximity Read ↗

More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancerSemantic proximity Read ↗

Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancerSemantic proximity Read ↗

Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapySemantic proximity Read ↗

The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: A meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.